DUBLIN, Oct. 21, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/h5kms3/2016_emerging) has announced the addition of the "2016 Emerging Growth Strategies for the US Hospital Hematology and Flow Cytometry Markets" report to their offering.
This new report contains 248 pages, 15 tables, and presents a comprehensive analysis of the US hospital hematology and flow cytometry markets, including:
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
For more information visit http://www.researchandmarkets.com/research/h5kms3/2016_emerging
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article